Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis

Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis

(2016) A. Dorothee Heemskerk et al.   NEW ENGLAND JOURNAL OF MEDICINE

The blood-brain barrier is disrupted by matrix metalloproteinases in tuberculous meningitis

(2015) Sara Brilha et al.   JOURNAL OF INFECTION

Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study

(2015) Hakan Erdem et al.   JOURNAL OF NEUROLOGY

Cerebrospinal fluid cytokines and matrix metalloproteinases in human immunodeficiency seropositive and seronegative patients of tuberculous meningitis

(2014) RavindraKumar Garg et al.   Annals of Indian Academy of Neurology

Doxycycline and HIV Infection Suppress Tuberculosis-induced Matrix Metalloproteinases

(2012) Naomi F. Walker et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Matrix metalloproteinases in tuberculosis

(2011) P. T. Elkington et al.   EUROPEAN RESPIRATORY JOURNAL

MMPs in tuberculosis: granuloma creators and tissue destroyers

(2011) Padmini Salgame   JOURNAL OF CLINICAL INVESTIGATION

Tuberculous meningitis: a uniform case definition for use in clinical research

(2010) Suzaan Marais et al.   LANCET INFECTIOUS DISEASES

Cerebrospinal fluid concentrations of antituberculosis agents in adults and children

(2010) P.R. Donald   TUBERCULOSIS

British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children

(2009) Guy Thwaites et al.   JOURNAL OF INFECTION

Dexamethasone, Cerebrospinal Fluid Matrix Metalloproteinase Concentrations and Clinical Outcomes in Tuberculous Meningitis

(2009) Justin A. Green et al.   PLoS One

Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium

(2009) H. E. Volkman et al.   SCIENCE